ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 28 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,907,008 | $21,244,000 | 14.99% |
| Third Rock Ventures, LLC | 4,841,591 | $53,935,000 | 6.29% |
| Broadfin Capital, LLC | 857,715 | $9,555,000 | 1.00% |
| NJ State Employees Deferred Compensation Plan | 25,000 | $278,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 112,485 | $1,253,000 | 0.05% |
| C WorldWide Group Holding A/S | 100,000 | $1,161,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 9,921 | $111,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 19,997 | $223,000 | 0.01% |
| Ground Swell Capital, LLC | 402 | $4,000 | 0.01% |
| Point72 Asset Management, L.P. | 55,450 | $618,000 | 0.01% |